STERIS EBITDA 2010-2025 | STE
STERIS annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- STERIS EBITDA for the quarter ending June 30, 2025 was $0.365B, a 22.54% increase year-over-year.
- STERIS EBITDA for the twelve months ending June 30, 2025 was $1.410B, a 3.02% increase year-over-year.
- STERIS 2025 annual EBITDA was $1.343B, a 4.5% decline from 2024.
- STERIS 2024 annual EBITDA was $1.406B, a 4.06% increase from 2023.
- STERIS 2023 annual EBITDA was $1.351B, a 23.12% increase from 2022.
| STERIS Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $1,343 |
| 2024 | $1,406 |
| 2023 | $1,351 |
| 2022 | $1,098 |
| 2021 | $768 |
| 2020 | $734 |
| 2019 | $637 |
| 2018 | $578 |
| 2017 | $473 |
| 2016 | $357 |
| 2015 | $319 |
| 2014 | $282 |
| 2013 | $312 |
| 2012 | $285 |
| 2011 | $140 |
| 2010 | $260 |
| 2009 | $238 |
| STERIS Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-06-30 | $365 |
| 2025-03-31 | $339 |
| 2024-12-31 | $371 |
| 2024-09-30 | $335 |
| 2024-06-30 | $298 |
| 2024-03-31 | $355 |
| 2023-12-31 | $372 |
| 2023-09-30 | $344 |
| 2023-06-30 | $336 |
| 2023-03-31 | $405 |
| 2022-12-31 | $329 |
| 2022-09-30 | $321 |
| 2022-06-30 | $297 |
| 2022-03-31 | $358 |
| 2021-12-31 | $322 |
| 2021-09-30 | $320 |
| 2021-06-30 | $98 |
| 2021-03-31 | $203 |
| 2020-12-31 | $204 |
| 2020-09-30 | $196 |
| 2020-06-30 | $165 |
| 2020-03-31 | $209 |
| 2019-12-31 | $192 |
| 2019-09-30 | $176 |
| 2019-06-30 | $157 |
| 2019-03-31 | $191 |
| 2018-12-31 | $152 |
| 2018-09-30 | $153 |
| 2018-06-30 | $141 |
| 2018-03-31 | $157 |
| 2017-12-31 | $148 |
| 2017-09-30 | $144 |
| 2017-06-30 | $129 |
| 2017-03-31 | $110 |
| 2016-12-31 | $116 |
| 2016-09-30 | $120 |
| 2016-06-30 | $127 |
| 2016-03-31 | $152 |
| 2015-12-31 | $92 |
| 2015-09-30 | $46 |
| 2015-06-30 | $67 |
| 2015-03-31 | $90 |
| 2014-12-31 | $83 |
| 2014-09-30 | $81 |
| 2014-06-30 | $65 |
| 2014-03-31 | $80 |
| 2013-12-31 | $75 |
| 2013-09-30 | $68 |
| 2013-06-30 | $59 |
| 2013-03-31 | $86 |
| 2012-12-31 | $85 |
| 2012-09-30 | $78 |
| 2012-06-30 | $63 |
| 2012-03-31 | $91 |
| 2011-12-31 | $70 |
| 2011-09-30 | $63 |
| 2011-06-30 | $61 |
| 2011-03-31 | $72 |
| 2010-12-31 | $49 |
| 2010-09-30 | $68 |
| 2010-06-30 | $-50 |
| 2010-03-31 | $66 |
| 2009-12-31 | $74 |
| 2009-09-30 | $64 |
| 2009-06-30 | $57 |
| 2009-03-31 | $63 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $24.578B | $5.460B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $186.846B | 22.60 |
| Intuitive Surgical (ISRG) | United States | $172.230B | 71.39 |
| IDEXX Laboratories (IDXX) | United States | $51.191B | 53.28 |
| Edwards Lifesciences (EW) | United States | $47.784B | 31.67 |
| Alcon (ALC) | Switzerland | $39.973B | 26.83 |
| IQVIA Holdings (IQV) | United States | $32.647B | 18.45 |
| DexCom (DXCM) | United States | $32.027B | 48.04 |
| Mettler-Toledo (MTD) | United States | $27.126B | 32.20 |
| Waters (WAT) | United States | $17.663B | 24.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.277B | 0.00 |
| Hologic (HOLX) | United States | $15.294B | 16.57 |
| Penumbra (PEN) | United States | $9.973B | 72.86 |
| Sysmex ADR (SSMXY) | Japan | $8.372B | 26.60 |
| Globus Medical (GMED) | United States | $8.202B | 18.92 |
| Masimo (MASI) | United States | $7.912B | 26.63 |
| Teleflex (TFX) | United States | $5.553B | 8.96 |
| Glaukos (GKOS) | United States | $5.215B | 0.00 |
| TransMedics (TMDX) | United States | $4.155B | 63.15 |
| Integer Holdings (ITGR) | United States | $3.759B | 18.76 |
| LivaNova (LIVN) | United Kingdom | $2.915B | 16.68 |
| Alphatec Holdings (ATEC) | United States | $2.351B | 0.00 |
| Veracyte (VCYT) | United States | $2.320B | 32.05 |
| PROCEPT BioRobotics (PRCT) | United States | $2.191B | 0.00 |
| Artivion (AORT) | United States | $2.030B | 102.43 |
| Nihon Kohden (NHNKY) | Japan | $1.894B | 22.61 |
| Elekta AB (EKTAY) | Sweden | $1.854B | 17.34 |
| Integra LifeSciences Holdings (IART) | United States | $1.111B | 6.37 |
| OPKO Health (OPK) | United States | $1.103B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.073B | 0.00 |
| IRadimed (IRMD) | United States | $0.888B | 43.10 |
| Tandem Diabetes Care (TNDM) | United States | $0.722B | 0.00 |
| AxoGen (AXGN) | United States | $0.716B | 0.00 |
| SiBone (SIBN) | United States | $0.670B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.665B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.574B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.527B | 9.31 |
| OrthoPediatrics (KIDS) | United States | $0.488B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.462B | 3.71 |
| Treace Medical Concepts (TMCI) | United States | $0.451B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.381B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.379B | 9.63 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.361B | 86.08 |
| RxSight (RXST) | United States | $0.346B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.286B | 19.72 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.234B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.223B | 0.00 |
| Neuronetics (STIM) | United States | $0.220B | 0.00 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| Inogen (INGN) | United States | $0.199B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Accuray (ARAY) | United States | $0.170B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.150B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.148B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.128B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.112B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.109B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.100B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.095B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.073B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 23.33 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.027B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.023B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Vyome Holdings (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.33 |